0001209191-19-007761.txt : 20190206 0001209191-19-007761.hdr.sgml : 20190206 20190206164618 ACCESSION NUMBER: 0001209191-19-007761 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190204 FILED AS OF DATE: 20190206 DATE AS OF CHANGE: 20190206 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ALTSHULER DAVID CENTRAL INDEX KEY: 0001550395 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 19572048 MAIL ADDRESS: STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED STREET 2: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-02-04 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001550395 ALTSHULER DAVID C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 0 1 0 0 EVP, Global Research and CSO Common Stock 2019-02-04 4 M 0 1796 91.05 A 40909 D Common Stock 2019-02-04 4 S 0 1796 189.19 D 39113 D Common Stock 2019-02-04 4 M 0 2330 86.52 A 41443 D Common Stock 2019-02-04 4 S 0 2330 189.19 D 39113 D Stock Option (Right to Buy) 91.05 2019-02-04 4 M 0 1796 0.00 D 2026-02-01 Common Stock 1796 7184 D Stock Option (Right to Buy) 86.52 2019-02-04 4 M 0 2330 0.00 D 2027-02-02 Common Stock 2330 18639 D Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1. The option vests in 16 quarterly installments from 02/02/2016. The option vests in 16 quarterly installments from 02/03/2017. /s/ Omar White, Attorney-in-Fact 2019-02-06